Carbapenemase-producing bacteria have become a major concern. Earlier only nosocomial pathogens such as *Pseudomonas aeruginosa* and *Acinetobacter baumannii* had significant carbapenem resistance, however, the emergence of carbapenemases in *Enterobacteriaceae* is a growing public health problem worldwide because of their high prevalence, wide range of clinical infections, multidrug resistance and rapid dissemination of plasmid-mediated resistance genes from *Enterobacteriaceae* to other organisms. These enzymes confer resistance to the other β-lactam agents as well and are generally co-associated with resistance genes for aminoglycosides, quinolones and have brought us a step closer to the challenge of extremely drug-resistant bacteria[@ref1][@ref2]. This study was designed to study molecular epidemiology of carbapenem-resistant bacterial isolates from community and hospital settings from north India and further explore therapeutic options for management of infections caused by carbapenem-resistant Gram-negative bacteria (GNB).

Material & Methods {#sec1-2}
==================

The present study was conducted from August 2014 to July 2016 at the department of Microbiology, Ganesh Shankar Vidyarthi Memorial Medical College (GSVM), Kanpur, India. The clinical specimens were collected from primary Health Centre Kalyanpur, district hospital Kanpur and LLRM Hospital, a tertiary care centre attached with GSVM Medical College, Kanpur. The study was cleared by the Institutional Ethics Committee.

Non-duplicate GNB isolated from various specimens were identified using conventional techniques[@ref3]. Antimicrobial susceptibility was performed by Kirby Bauer disk diffusion method[@ref3] and minimum inhibitory concentration (MIC) breakpoints of carbapenems for the isolates which were resistant by disc diffusion testing was determined by *E*-test (BioMérieux, France). Further to look for treatment options for these carbapenem-resistant isolates MIC of other antibiotics such as fosfomycin, minocycline, chloramphenicol and tigecycline was also determined using E Strip and colistin MIC was determined using broth microdilution method, results were interpreted as per Clinical and Laboratory Standards Institute (CLSI) guidelines[@ref4].

The isolation of genomic DNA of carbapenem-resistant bacteria was done by QuiAmp mini DNA extraction kit (Qualigens, Germany) and multiplex PCR was performed to identify the presence of following genes *bla*~IMP~, *bla*~VIM~, *bla*~KPC~, *bla*~OXA48~, *bla*~OXA23~, *bla*~SPM~, *bla*~GIM~, *bla*~SIM~ and *bla*~NDM~ using the primers and protocol described earlier[@ref5]. New Delhi metallo-β-lactamase (NDM) positive amplicons were sequenced and previously published sequences of NDM isolates retrieved from the National Center for Biotechnology (*<http://www.ncbi.nlm.nih.gov>*) were used as the reference sequence for result interpretation. Phenotypic tests such as modified Hodge test (MHT)[@ref1], metallo-β-lactamase (MBL), E-strip test[@ref1], Neo-Sensitabs Test (Rosco Diagnostica, Denmark) and Rapidec Carba NP Test (BioMérieux, France)[@ref6] were performed on carbapenem-resistant PCR-positive bacterial isolates.

Results & Discussion {#sec1-3}
====================

A total of 8973 samples were processed and 3414 GNB were isolated; of which 312 (9.20%) isolates were carbapenem-resistant. Maximum resistance (11.2%) was present at tertiary care centre, followed by secondary care (4.0%) and primary centre (2.1%). Amongst the carbapenem-resistant bacteria; overall, the most common isolate was *Pseudomones aeruginosa* (24%) followed by *Acinetobacter* spp. (22%) and *Escherichia coli* (16%) ([Table I](#T1){ref-type="table"}). In a community-based study from south India Sekar *et al*[@ref7] also documented three per cent carbapenem resistance in members of *Enterobacteriaceae*, however in the treatment guidelines document released by the Indian Council of Medical Research[@ref8], surveillance data were collected and compiled from four tertiary care centres in India, and a high meropenem resistance of 42, 47 and 62 per cent was reported among members of *Enterobacteriaceae, P. aeruginosa* and *A. baumannii*, respectively.

###### 

Aetiology of carbapenem resistant bacteria isolated from different healthcare level

  Health-care setting              Total GNB grown   Number and per cent of carbapenem resistant bacteria   Aetiology of carbapenem resistant bacteria   n
  -------------------------------- ----------------- ------------------------------------------------------ -------------------------------------------- -----
  Primary                          237               5 (2.11)                                               *Escherichia coli*                           3
  *Pseudomonas aeruginosa*         1                                                                                                                     
  *Acinetobacter* spp.             1                                                                                                                     
  Secondary                        698               28 (4)                                                 *E. coli*                                    8
  *P. aeruginosa*                  10                                                                                                                    
  *Acinetobacter* spp.             8                                                                                                                     
  *Klebsiella pneumoniae*          2                                                                                                                     
  Tertiary                         2479              279 (9.75)                                             *P. aeruginosa*                              64
  *Acinetobacter* spp.             62                                                                                                                    
  *E. coli*                        39                                                                                                                    
  *K. pneumoniae*                  22                                                                                                                    
  *Enterobacter* sp.               16                                                                                                                    
  *Proteus* spp.                   15                                                                                                                    
  *Citrobacter* sp.                18                                                                                                                    
  *Providencia* sp.                12                                                                                                                    
  *Morganella morganii*            9                                                                                                                     
  *Alcaligenes faecalis*           8                                                                                                                     
  *Stenotrophomonas maltophilia*   5                                                                                                                     
  Unidentified                     9                                                                                                                     
  Total                            3414              312 (9.20)                                                                                          312

GNB, Gram-negative bacteria

On multiplex PCR 282 of 312 (90.3%) isolates were positive *f* or carbapenemase gene. The *bla*~NDM~ 178 (63%) was the most prevalent gene followed by *bla*~VIM~ (18.4%). The *bla*~KPC~, *bla*~GIM~ and *bla*~SIM~ were not isolated in this study; *bla*~NDM~ and *bla*~OXA48~ were co-observed in 20 per cent isolates ([Table II](#T2){ref-type="table"}). Sequencing was performed on 178 *bla*~NDM~ positive isolates and 133 (75%) isolates were carrying *bla*~NDM-1~ and the rest were harbouring *bla*~NDM-5~ genes. The findings were in concurrence to previously published reports from India[@ref9][@ref10]. Some NDM-positive isolates were earlier screened for the coexistence of ESBL genes, 16s methyltransferase genes determining aminoglycosides resistance and quinolones resistance determinants and it was found that NDM positive isolates were co-harbouring several other resistance determinants[@ref11]. In contrast to western literature[@ref1], *bla*~KPC~ was not isolated in this study.

###### 

Molecular epidemiology of carbapenem resistant Gram-negative bacteria

  Organism                                      Total number isolated   Carbapenemase producing gene                                  
  --------------------------------------------- ----------------------- ------------------------------ ---- ---- --- ---- --- --- --- ---
  Members of family Enterobacteriacae (n=144)                                                                                         
  *Escherichia coli*                            50                      25                             11   6    2   0    0   3   0   0
  *Klebsiella pneumoniae*                       24                      7                              8    5    1   0    0   2   0   0
  *Enterobacter* sp.                            16                      4                              6    2    1   0    0   1   0   0
  *Proteus* spp.                                15                      8                              2    3    0   0    0   0   0   0
  *Citrobacter* sp.                             18                      10                             3    4    0   0    0   0   0   0
  *Providencia* sp.                             12                      6                              0    2    0   0    0   0   0   0
  *Morganella morganii*                         9                       6                              0    2    0   0    0   0   0   0
  Non-fermenters (n=159)                                                                                                              
  *Pseudomonas aeruginosa*                      75                      53                             0    14   1   0    0   1   0   0
  *Acinetobacter baumannii* complex             71                      51                             0    12   0   10   0   0   0   0
  *Alcaligenes faecalis*                        8                       4                              0    2    0   0    0   0   0   0
  *Stenotrophomonas maltophilia*                5                       4                              0    0    0   0    0   0   0   0
  Unidentified bacteria (n=9)                                                                                                         
  Unidentified bacteria                         9                       0                              0    0    0   0    0   0   0   0
  Total                                         312                     178                            30   52   5   10   0   7   0   0

Phenotypic carbapenemase detection test was performed on 261 PCR confirmed isolates.

Rapidec Carba NP test, Neo-Sensitabs and MHT and showed a sensitivity of 90, 73 and 20 per cent, respectively. MIC of the isolates resistant to carbapenem was determined for other antibiotics such as chloramphenicol, colistin, fosfomycin, minocycline and tigecycline ([Table III](#T3){ref-type="table"}).

###### 

Antimicrobial susceptibility pattern of carbapenem resistant Gram-negative bacteria (GNB)

  Tested bacteria                           Colistin (per cent sensitive)   Tigecycline (per cent sensitive)   Minocycline (per cent sensitive)   Chloramphenicol (per cent sensitive)   Fosfomycin (per cent sensitive)
  ----------------------------------------- ------------------------------- ---------------------------------- ---------------------------------- -------------------------------------- ---------------------------------
  Members of *Enterobacteriaceae* (n=161)   \-                              64                                 52                                 35                                     88
  *P. aeruginosa* (n=75)                    78                              \-                                 \-                                 \-                                     \-
  *Acinetobacter* spp. (n=71)               85                              \-                                 70                                 \-                                     \-

Carbapenemases are generally encoded by a genetic element found on different plasmids that may jump from bacteria to bacteria easily causing the rapid emergence of multidrug-resistant bacteria[@ref1]. Thus for carbapenem-resistant isolates MIC was also determined for chloramphenicol, colistin, fosfomycin, minocycline and tigecycline. Fosfomycin which was previously used mainly as oral treatment for uncomplicated urinary tract infections, currently attracts clinicians' interest worldwide. Particularly, the reported activity against pathogens with advanced resistance suggests that this antibiotic may provide a useful option for the treatment of patients with these difficult to treat infections[@ref12]. In our study 88 per cent CRE were sensitive to fosfomycin.

Colistin and polymyxin B have recently regained significant interest as a consequence of the increasing incidence of infections due to carbapenem-resistant bacteria and are reconsidered as last-resort antibiotics[@ref13]. Results of this study demonstrated that 78 per cent of *P. aeruginosa* and 85 per cent *Acinetobacter* spp. were sensitive to colistin. Indian data on colistin resistance from ICMR document[@ref8] reported colistin resistance of 10 per cent in *P. aeruginosa* and 22 per cent in *A. baumannii* complex. Another study from north India reported colistin resistance in carbapenem resistance *A. baumannii* as 16 per cent[@ref14]. The use of polymyxins has been challenged by the emergence of the plasmid-borne mobile colistin resistance gene (*mcr-1*)[@ref15]. Since MCR-1 is capable of horizontal transfer between different strains of a bacterial species and after its discovery in November 2015 in *E. coli* (strain SHP45) from a pig in China, it has been found in *E. coli*, *Salmonella enterica, Klebsiella pneumonia, Enterobacter aerogenes* and *Enterobacter cloacae*[@ref15].

Results of our study show that 70 per cent of *Acinetobacter* spp. and 50 per cent carbapenem-resistant enterobacteriaceae (CRE) were sensitive to minocycline. The study results were in concurrence to other Indian and western literature[@ref16][@ref17]. Tigecycline is a structural analogue of minocycline that was designed to avoid tetracycline resistance mediated by ribosomal protection and drug efflux[@ref18]. It is indicated for the treatment of complicated skin infections, intra-abdominal infections and community-acquired bacterial pneumonia[@ref19]. This study results showed 36 per cent tigecycline resistance in CRE in concurrence with other Indian studies[@ref20][@ref21].

In conclusion, carbapenem resistance in the GNB from the community and hospital settings is on rise and should be closely monitored. In the absence of new antibiotics in pipeline and limited therapeutic options, it is important to prudently use antibiotics and strict infection control practices should be followed in the hospital to limit the emergence and spread of multidrug-resistant bacteria.
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